209 related articles for article (PubMed ID: 36625748)
1. Percentages of Hepatocellular Carcinoma in LI-RADS Categories with CT and MRI: A Systematic Review and Meta-Analysis.
Lee S; Kim YY; Shin J; Son WJ; Roh YH; Choi JY; Sirlin CB; Chernyak V
Radiology; 2023 Apr; 307(1):e220646. PubMed ID: 36625748
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF
Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016
[TBL] [Abstract][Full Text] [Related]
3. Liver Imaging Reporting and Data System version 2018 category 5 for diagnosing hepatocellular carcinoma: an updated meta-analysis.
Lee S; Kim YY; Shin J; Roh YH; Choi JY; Chernyak V; Sirlin CB
Eur Radiol; 2024 Mar; 34(3):1502-1514. PubMed ID: 37656177
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of prospective application of the Liver Imaging Reporting and Data System (LI-RADS) in gadoxetate-enhanced MRI.
Kim YY; An C; Kim S; Kim MJ
Eur Radiol; 2018 May; 28(5):2038-2046. PubMed ID: 29230525
[TBL] [Abstract][Full Text] [Related]
5. CT and MRI Liver Imaging Reporting and Data System Version 2018 for Hepatocellular Carcinoma: A Systematic Review With Meta-Analysis.
Lee S; Kim YY; Shin J; Hwang SH; Roh YH; Chung YE; Choi JY
J Am Coll Radiol; 2020 Oct; 17(10):1199-1206. PubMed ID: 32640250
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of different LI-RADS v2018 categories in high-risk patients undergoing CT- or MRI-based screening for hepatocellular carcinoma.
Shahbazian H; Birnbaum J; Burns PJ; Shabanan SH; Kanmaniraja D; Reinus J; Kamel I; Sirlin CB; Chernyak V
Abdom Radiol (NY); 2023 Dec; 48(12):3696-3702. PubMed ID: 37725110
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic Performance of CT/MRI Liver Imaging Reporting and Data System v2017 for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Lee S; Kim SS; Roh YH; Choi JY; Park MS; Kim MJ
Liver Int; 2020 Jun; 40(6):1488-1497. PubMed ID: 32145134
[TBL] [Abstract][Full Text] [Related]
8. A modified LI-RADS: targetoid tumors with enhancing capsule can be diagnosed as HCC instead of LR-M lesions.
Min JH; Kim JM; Kim YK; Kim H; Choi GS; Kang TW; Cha D; Hwang JA; Ko SE; Ahn S
Eur Radiol; 2022 Feb; 32(2):912-922. PubMed ID: 34345947
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic performance of CT versus MRI Liver Imaging Reporting and Data System category 5 for hepatocellular carcinoma: a systematic review and meta-analysis of comparative studies.
Kim YY; Lee S; Shin J; Son WJ; Roh YH; Hwang JA; Lee JE
Eur Radiol; 2022 Oct; 32(10):6723-6729. PubMed ID: 35849177
[TBL] [Abstract][Full Text] [Related]
10. MRI-diagnosis of category LR-M observations in the Liver Imaging Reporting and Data System v2018: a systematic review and meta-analysis.
Shin J; Lee S; Hwang JA; Lee JE; Chung YE; Choi JY; Park MS
Eur Radiol; 2022 May; 32(5):3319-3326. PubMed ID: 35031839
[TBL] [Abstract][Full Text] [Related]
11. A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT.
Hong CW; Chernyak V; Choi JY; Lee S; Potu C; Delgado T; Wolfson T; Gamst A; Birnbaum J; Kampalath R; Lall C; Lee JT; Owen JW; Aguirre DA; Mendiratta-Lala M; Davenport MS; Masch W; Roudenko A; Lewis SC; Kierans AS; Hecht EM; Bashir MR; Brancatelli G; Douek ML; Ohliger MA; Tang A; Cerny M; Fung A; Costa EA; Corwin MT; McGahan JP; Kalb B; Elsayes KM; Surabhi VR; Blair K; Marks RM; Horvat N; Best S; Ash R; Ganesan K; Kagay CR; Kambadakone A; Wang J; Cruite I; Bijan B; Goodwin M; Moura Cunha G; Tamayo-Murillo D; Fowler KJ; Sirlin CB
Radiology; 2023 Jun; 307(5):e222855. PubMed ID: 37367445
[TBL] [Abstract][Full Text] [Related]
12. Intraindividual Comparison of Contrast-Enhanced Ultrasound Using Perfluorobutane With Modified Criteria Versus CT/MRI LI-RADS Version 2018 for Diagnosing HCC in High-Risk Patients.
Li L; Mao S; Wang J; Zheng W; Shen J; Clevert DA; Zhou J
AJR Am J Roentgenol; 2023 May; 220(5):682-691. PubMed ID: 36382914
[No Abstract] [Full Text] [Related]
13. CT/MRI and CEUS LI-RADS Major Features Association with Hepatocellular Carcinoma: Individual Patient Data Meta-Analysis.
van der Pol CB; McInnes MDF; Salameh JP; Levis B; Chernyak V; Sirlin CB; Bashir MR; Allen BC; Burke LMB; Choi JY; Choi SH; Forner A; Fraum TJ; Giamperoli A; Jiang H; Joo I; Kang Z; Kierans AS; Kang HJ; Khatri G; Kim JH; Kim MJ; Kim SY; Kim YY; Kwon H; Lee JM; Lewis SC; McGinty KA; Mulazzani L; Park MS; Piscaglia F; Podgórska J; Reiner CS; Ronot M; Rosiak G; Song B; Song JS; Tang A; Terzi E; Wang J; Wang W; Wilson SR; Yokoo T
Radiology; 2022 Feb; 302(2):326-335. PubMed ID: 34783596
[TBL] [Abstract][Full Text] [Related]
14. Contrast-enhanced ultrasound LI-RADS 2017: comparison with CT/MRI LI-RADS.
Ding J; Long L; Zhang X; Chen C; Zhou H; Zhou Y; Wang Y; Jing X; Ye Z; Wang F
Eur Radiol; 2021 Feb; 31(2):847-854. PubMed ID: 32803416
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of LI-RADS Version 2018 for Evaluation of Pediatric Hepatocellular Carcinoma.
Khanna G; Chavhan GB; Schooler GR; Fraum TJ; Alazraki AL; Squires JH; Salter A; Podberesky DJ; Towbin AJ
Radiology; 2021 Apr; 299(1):190-199. PubMed ID: 33620289
[TBL] [Abstract][Full Text] [Related]
16. The Liver Imaging Reporting and Data System tumor-in-vein category: a systematic review and meta-analysis.
Kim DH; Choi SH; Park SH; Kim KW; Byun JH; Kim SY; Lee SS; Choi JI
Eur Radiol; 2021 Apr; 31(4):2497-2506. PubMed ID: 33001305
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Performance of LI-RADS Treatment Response Algorithm for Hepatocellular Carcinoma: Adding Ancillary Features to MRI Compared with Enhancement Patterns at CT and MRI.
Park S; Joo I; Lee DH; Bae JS; Yoo J; Kim SW; Lee JM
Radiology; 2020 Sep; 296(3):554-561. PubMed ID: 32692297
[TBL] [Abstract][Full Text] [Related]
18. LI-RADS Version 2017 versus Version 2018: Diagnosis of Hepatocellular Carcinoma on Gadoxetate Disodium-enhanced MRI.
Lee SM; Lee JM; Ahn SJ; Kang HJ; Yang HK; Yoon JH
Radiology; 2019 Sep; 292(3):655-663. PubMed ID: 31310175
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic Performance of LI-RADS Version 2018, LI-RADS Version 2017, and OPTN Criteria for Hepatocellular Carcinoma.
Kierans AS; Song C; Gavlin A; Roudenko A; Lu L; Askin G; Hecht EM
AJR Am J Roentgenol; 2020 Nov; 215(5):1085-1092. PubMed ID: 32877248
[No Abstract] [Full Text] [Related]
20. Diagnostic performance of LI-RADS for MRI and CT detection of HCC: A systematic review and diagnostic meta-analysis.
Liang Y; Xu F; Guo Y; Lai L; Jiang X; Wei X; Wu H; Wang J
Eur J Radiol; 2021 Jan; 134():109404. PubMed ID: 33276248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]